Type of MS: RRMS|SPMS
Treatment mode of action: To improve cognition
Number of Subjects: 4
Medication: Ozanimod (RPC-1063)
Location: California
Institutions: SC3 Research - Pasadena
Contact Information
Roxanne Cabading, ext. 799
(626) 250 2070
roxanne.cabading@neurosearch-usa.com